Resumo Tendo em vista o crescente número de óbitos pela pandemia de COVID-19 no país, o presente trabalho apresenta análise descritiva inicial e exploratória sobre o excesso de mortalidade observado nos meses de março a maio de 2020 nas capitais e nos demais municípios do país. A fonte de dados utilizada foi o registro de óbitos pelos Cartórios de Registro Civil. Os dados foram desagregados por capitais e demais municípios das 26 unidades federativas e do Distrito Federal segundo sexo. A razão de mortalidade ajustada para o ano de 2020 foi calculada tendo como padrão os coeficientes de mortalidade do ano de 2019. Os resultados indicaram excesso de 39.146 óbitos para o período estudado, sendo maior entre homens do que nas mulheres. Esse aumento foi maior nas capitais das regiões Norte, Nordeste e Sudeste. Nos demais municípios dessas regiões o incremento foi observado em maio, indicando possível interiorização da transmissão da COVID-19. Evidencia-se a necessidade de se aprimorar a detecção e o registro de casos para viabilizar o monitoramento eficiente da pandemia.
22 December 2022 in The Lancet Regional Health - Americas
A nationwide Severe Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination campaign was initiated in Brazil in January 2021 with CoronaVac (Sinovac Biotech) and ChAdOx1 nCoV-19 (AstraZeneca) followed by BNT162b2 mRNA (Pfizer–BioNTech) and Ad26.COV2.S (Johnson & Johnson–Janssen) vaccines. Here we provide estimates of the number of severe cases and deaths due to coronavirus disease (COVID-19) averted during the first year of the mass vaccination campaign in Brazil. Data on COVID-19 vaccination and COVID-19-related illness and death were obtained from the Brazilian Ministry of Health and used to estimate the direct effects of the vaccination campaign on the number of severe cases and deaths due to COVID-19 occurring between January 17, 2021 and January 31, 2022. To this end, we compared the daily age-specific rates between the unvaccinated population and the “at least partly vaccinated” population (received at least one dose of a two-dose vaccine), as well as other two vaccination subgroups, “fully vaccinated” (completed the one- or two-dose vaccine schedule), and “boosted-vaccinated” (fully vaccinated and recipients of booster dose) populations. We estimated that 74% (n = 875,846; 95% confidence interval, CI 843,383–915,709) of total expected cases of severe COVID-19 and 82% (n = 303,129; 95% CI 284,019–321,681) of total expected deaths due to COVID-19 were averted in the first year of the national vaccination campaign. The averted burden was heterogeneous between age groups and higher in the more populous states. However, outcome rate differences between vaccinated and unvaccinated groups were higher in the less populated states. The first year of the COVID-19 vaccination program in Brazil saved the lives of at least 303,129 adults. The results highlight the need for future vaccination campaigns, including those required in the current pandemic, to rapidly achieve high uptake, particularly among the elderly and residents of the least populous regions. 10.13039/501100006506 Ministry of Health (Brazil) .
30 July 2022 in The Lancet Regional Health - Americas
COVID-19 serosurveys allow for the monitoring of the level of SARS-CoV-2 transmission and support data-driven decisions. We estimated the seroprevalence of anti-SARS-CoV-2 antibodies in a large favela complex in Rio de Janeiro, Brazil. A population-based panel study was conducted in Complexo de Manguinhos (16 favelas) with a probabilistic sampling of participants aged ≥1 year who were randomly selected from a census of individuals registered in primary health care clinics that serve the area. Participants answered a structured interview and provided blood samples for serology. Multilevel regression models (with random intercepts to account for participants’ favela of residence) were used to assess factors associated with having anti-S IgG antibodies. Secondary analyses estimated seroprevalence using an additional anti-N IgG assay. 4,033 participants were included (from Sep/2020 to Feb/2021, 22 epidemic weeks), the median age was 39·8 years (IQR:21·8-57·7), 61% were female, 41% were mixed-race (Pardo) and 23% Black. Overall prevalence was 49·0% (95%CI:46·8%-51·2%) which varied across favelas (from 68·3% to 31·4%). Lower prevalence estimates were found when using the anti-N IgG assay. Odds of having anti-S IgG antibodies were highest for young adults, and those reporting larger household size, poor adherence to social distancing and use of public transportation. We found a significantly higher prevalence of anti-S IgG antibodies than initially anticipated. Disparities in estimates obtained using different serological assays highlight the need for cautious interpretation of serosurveys estimates given the heterogeneity of exposure in communities, loss of immunological biomarkers, serological antigen target, and variant-specific test affinity. Fundação Oswaldo Cruz, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), the European Union's Horizon 2020 research and innovation programme, Royal Society, Serrapilheira Institute, and FAPESP.
25 August 2021 in Proceedings Of The Royal Society B-Biological Sciences
Vector-borne diseases (VBDs) are important contributors to the global disease burden and are a key factor in perpetuating economic inequality. Although environmental changes are often cited as drivers of VBDs, the link between deforestation and VBD occurrence remains unclear. Here, we examined this relationship in detail using the spread of visceral leishmaniasis (VL) in São Paulo state (Brazil) as the case study. We used a two-step approach to estimate the causal effects (overall, direct, and indirect) of deforestation on the occurrence of the VL vector, canine visceral leishmaniasis (CVL), and human visceral leishmaniasis (HVL). We first estimated the parameters via a double Metropolis–Hastings algorithm and then estimated the causal effects through a Gibbs sampler. We observed that the odds of vector, CVL, and HVL occurrence were 2.63-, 2.07-, and 3.18-fold higher, respectively, in deforested compared with forested municipalities. We also identified a significant influence of the presence of vector, CVL, and HVL in one municipality on disease occurrence in previously naive neighbouring municipalities. Lastly, we found that a hypothetical reduction in deforestation prevalence from 50 to 0% across the state would reduce vector, CVL, and HVL occurrence by 11%, 6.67%, and 29.87%, respectively. Our results suggest that implementing an eco-friendly development strategy that considers trade-offs between agriculture, urbanization, and conservation could be an effective mechanism of controlling VL.
1 January 2021 in Revista Brasileira de Epidemiologia
RESUMO: Este estudo analisou o fluxo intermunicipal das internações por síndrome respiratória aguda grave por COVID-19 na região metropolitana do Rio de Janeiro. Foram identificadas 12.676 internações intermunicipais por COVID-19 envolvendo o município do Rio de Janeiro. Dessas, 11.288 (89,0%) eram de residentes na região metropolitana, 87% de residentes em outros municípios da mesma região e internados na capital do estado, e 13% eram residentes da capital internados em outros municípios da região. Há correlação negativa entre a distância dos municípios e o fluxo origem-destino (r=0,62, p<0,001). O município do Rio de Janeiro importa mais internações por síndrome respiratória aguda grave por COVID-19 do que exporta. Este estudo evidenciou a importância das redes de atendimento para casos mais graves, os quais necessitem, principalmente, de atenção especializada.
18 December 2025 in International Journal of Epidemiology
Background: Population-based data on COVID-19’s impact are essential for informing public health policies, particularly in low- and middle-income countries. Here, we investigated the history of COVID-19 diagnoses across the Brazilian population, considering factors such as sex, age, skin colour/ethnicity, comorbidity, schooling, and socioeconomic level. Methods: In this nationwide study, EPICOVID 2.0, we surveyed 133 cities in all Brazilian states between March and June 2024. We randomly selected 250 households per city and one individual from each household. Crude and adjusted prevalence ratios were calculated to examine the association between covariates and self-reports of prior COVID-19 diagnoses and hospitalizations, and odds ratios to assess the factors associated with the higher number of COVID-19 episodes. Results: Our analysis of 33 250 individuals revealed that 28.6% [95% confidence interval (CI), 27.3–29.9] of the study population had a previous COVID-19 diagnosis, with most of those reported presenting one episode (77.7%), followed by two (17.3%) and three episodes (5.0%). We observed a positive association between higher educational attainment and wealth quintiles and self-reported COVID-19 diagnoses. We also found that women presented a higher COVID-19 prevalence. About 4.5% (95% CI, 3.8–5.2) of participants who reported previous COVID-19 were hospitalized, with an average length of stay of 10.4 days. We did not find a difference in the prevalence of hospitalizations between socioeconomic strata. We observed that those who experienced two or more COVID-19 episodes had three times higher odds of being hospitalized. Conclusion: These findings highlight significant disparities in the COVID-19 impact across socioeconomic and demographic groups in Brazil, underscoring the need for targeted public health interventions to address vulnerabilities and reduce the COVID-19 burden in Brazil.